Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6197 results
This entry is part 4 of 17 in the series Research Integrity
%postcontent%
A breast cancer cell seen through a special microscope.
  • Science & Technology

Can cancer cells communicate?

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too. Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

by Tim Gunn | Analysis | 28 February 2023

28 February 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023

In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton. In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton.

by Phil Prime | Podcast | 14 February 2023

14 February 2023

This entry is part 9 of 9 in the series Cancer Research Matters - series 1
%postcontent%
Glioblastoma cells seen through a microscope.

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

by Tim Gunn | Analysis | 13 February 2023

13 February 2023

Michelle Mitchell, CEO of CRUK

For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them. For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them.

by Michelle Mitchell | Opinion | 11 February 2023

11 February 2023

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily. We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

by Cancer Research UK | In depth | 10 February 2023

10 February 2023

Kizi, who was diagnosed with breast cancer, with some of the information leaflets he was given

Kizi and his wife Emma share the challenges they faced when he was diagnosed with a cancer that predominantly affects the opposite sex: a whirlwind of change and female-centred care. Kizi and his wife Emma share the challenges they faced when he was diagnosed with a cancer that predominantly affects the opposite sex: a whirlwind of change and female-centred care.

by Elisa Mitchell | Personal stories | 7 February 2023

7 February 2023

Michelle Mitchell chief executive Cancer Research UK

By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires? By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires?

by Michelle Mitchell | Opinion | 6 February 2023

6 February 2023